Core Insights - Varian Medical Systems has launched its global first SmART intelligent adaptive radiotherapy solution at the 8th China International Import Expo, enhancing cancer treatment efficiency and accessibility [1][2] - The company has a strong foundation in the Chinese market, having operated there for over 40 years and continuously investing in local production and R&D capabilities [1] Group 1 - The SmART solution automates the detection of tumor changes and provides personalized treatment plans, functioning like an "intelligent radiotherapy assistant" [1] - Varian's President for Greater China, Qian Shenglai, emphasized that the intelligent and streamlined system will improve the quality of cancer treatment for more patients [1] - The product launch is a result of Varian's long-term commitment to the Chinese market, including the establishment of a global innovation center in Beijing in 2022 [1] Group 2 - The China International Import Expo serves as a significant platform for international collaboration in clinical medicine, allowing innovations to rapidly benefit patients [2] - Varian aims to leverage the expo's international influence to foster open and win-win cooperation, accelerating the implementation of innovative solutions in China [2]